| Record ID | marc_columbia/Columbia-extract-20221130-008.mrc:510588864:1775 |
| Source | marc_columbia |
| Download Link | /show-records/marc_columbia/Columbia-extract-20221130-008.mrc:510588864:1775?format=raw |
LEADER: 01775cam a2200421 a 4500
001 3955139
005 20221027005624.0
008 910122s1990 ne b a 000 0 eng c
010 $a 90005267
020 $a0792309456 (alk. paper)
035 $a(OCoLC)22345557
035 $a(OCoLC)ocm22345557
035 $a(CStRLIN)NYCM91-B420
035 $9AEX8560HS
035 $a(NNC)3955139
035 $a3955139
040 $aDNLM/DLC$cDLC$dNNC-M
050 00 $aRS380$b.F76 1990
060 0 $aQW 575 F931
082 00 $a615/.7$220
245 00 $aFrom clone to clinic /$cedited by D.J.A. Crommelin and H. Schellekens.
260 $aDordrecht ;$aBoston :$bKluwer Academic Publishers,$c1990.
300 $axvi, 378 pages :$billustrations ;$c25 cm.
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
490 1 $aDevelopments in biotherapy ;$vv. 1
504 $aIncludes bibliographical references.
650 0 $aPharmaceutical biotechnology.$0http://id.loc.gov/authorities/subjects/sh90004049
650 0 $aMonoclonal antibodies.$0http://id.loc.gov/authorities/subjects/sh85005650
650 2 $aAntibodies, Monoclonal$xtherapeutic use.$0https://id.nlm.nih.gov/mesh/D000911Q000627
650 2 $aBiological Factors$xstandards.$0https://id.nlm.nih.gov/mesh/D001685Q000592
650 2 $aCloning, Molecular.$0https://id.nlm.nih.gov/mesh/D003001
650 2 $aDNA, Recombinant.$0https://id.nlm.nih.gov/mesh/D004274
650 2 $aGenetic Engineering.$0https://id.nlm.nih.gov/mesh/D005818
700 1 $aCrommelin, D. J. A.$q(Daan J. A.)$0http://id.loc.gov/authorities/names/n89138187
700 1 $aSchelleken, Huub.
830 0 $aDevelopments in biotherapy ;$vv. 1.$0http://id.loc.gov/authorities/names/n88525786
852 00 $boff,hsl$hRS380$i.F76 1990